Cargando...
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial Antigen Presenting Cells (aAPC)
Adoptive immunotherapy for treatment of cancers and infectious diseases is often hampered by a high degree of variability in the final T cell product and the limited in vivo function and survival of ex vivo expanded antigen-specific cytotoxic T cells (CTL). This has stimulated interest in developmen...
Gardado en:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2680120/ https://ncbi.nlm.nih.gov/pubmed/18563409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-008-0542-1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|